Financial statements Pharmazone

Balance sheet of Pharmazone

Company age:
Age:
10 y. 9 m. 9 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of PHARMAZONE

Year
2018
2019
2021
2022
2023
Total assets 6 041 480,04 6 515 074,28 7 642 111,47 8 184 063,21 7 539 521,32
A. Fixed assets 859 574,32 599 838,73 357 071,47 337 889,68 460 063,45
B. Current assets 5 181 905,72 5 915 235,55 7 285 040,00 7 846 173,53 7 079 457,87
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 6 041 480,04 6 515 074,28 7 642 111,47 8 184 063,21 7 539 521,32
A. Equity 4 250 887,90 4 559 106,83 6 043 592,44 6 176 600,06 5 948 866,45
B. Liabilities and provisions for liabilities 1 790 592,14 1 955 967,45 1 598 519,03 2 007 463,15 1 590 654,87
I. Long-term liabilities - - - - -
II. Short-term liabilities 1 790 592,14 1 955 967,45 1 598 519,03 2 007 463,15 1 590 654,87
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.